Back

Mitral regurgitation in obstructive hypertrophic cardiomyopathy: assessing the impact of mavacamten

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: Imaging in cardiomyopathy Myocardial Disease EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Yande Kasolo

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Propensity score-matched analysis in isolated left ventricular dilation and non-ischaemic dilated cardiomyopathy
Doctor T. Goncalves (Toronto, CA)
Abstract Slides
Presentation thumbnail
Clinical significance of right ventricular - pulmonary arterial uncoupling in hypertrophic cardiomyopathy
Professor A. Timoteo (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Incidence, predictors and outcomes associated with pacemaker implantation in transthyretin cardiac amyloidosis
Doctor S. Istratoaie (Cluj Napoca, RO)
Abstract Slides

Access the full session

Session thumbnail
Imaging in cardiomyopathy

The Event

Event poster

EuroEcho-Imaging 2024

11 December - 13 December 2024
You may be interested in
thumbnail
Congress Presentation
Echocardiography as first-line technique in suspected cardiac amyloidosis
thumbnail
Congress Presentation
What is the best imaging method to assess myocardial viability? 
thumbnail
Congress Presentation
Dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources